To read the full story, subscribe or sign in.

RU-58841 shows potential as topical agent for alopecia and other skin disorders

Oct. 28, 1998

No Comments

BioWorld Science Dermatologic

Today's news in brief

BioWorld

BioWorld briefs for Jan. 22, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for January 22, 2025

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

BioWorld

The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...

Proteomics study explores how protein changes influence disease

BioWorld Science

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...

Illustration of cell receptors, antibodies

Abbvie and Simcere enter a $1B T-cell engager deal

BioWorld Asia

Abbvie Inc. and Simcere Zaiming Pharmaceutical Co. Ltd. are part of the volley of large deals accompanying the opening of the 43rd annual J.P. Morgan Healthcare...

Upgrade your daily dose of biopharma and medtech news

RU-58841 shows potential as topical agent for alopecia and other skin disorders